GROZvsLRNDETF Comparison
Zacks Focus Growth ETF (GROZ) belongs to the US Large Cap Growth segment. NYLI U.S. Large Cap R&D Leaders ETF (LRND) is part of the US Large Cap segment. GROZ's top 3 sector exposures are Technology, Consumer Non-Cyclicals and Healthcare. In contrast, LRND's top sector exposures are Technology, Healthcare and Consumer Non-Cyclicals. GROZ is more expensive with a Total Expense Ratio (TER) of 1.14%, versus 0.15% for LRND. GROZ is up 9.05% year-to-date (YTD) with +$52M in YTD flows. LRND performs better with 12.6% YTD performance, and +$325M in YTD flows. Run a side-by-side ETF comparison of GROZ and LRND below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
GROZ vs LRND performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | GROZ LRND | -2.46%-2.26% | +1.03%+2.55% | +9.05%+12.60% | +11.95%+17.10% | n/a+79.89% | n/an/a |
| Flows | GROZ LRND | +$6M+$31M | +$18M+$48M | +$52M+$325M | +$69M+$383M | -+$384M | -- |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | GROZ LRND | +16.05%+16.14% | +16.28%+16.91% | n/a+17.76% | n/an/a |
| Max drawdown | GROZ LRND | -6.22%-4.90% | -13.75%-13.88% | n/a-20.97% | n/an/a |
| Max drawdown duration | GROZ LRND | 19d23d | 183d169d | n/a126d | n/an/a |
GROZ | LRND | |
Last sale 9/15/2026 at 1:30 PM | $32.51 | $45.78 |
| Previous close 09/15/2026 | $32.71 | $46.01 |
| Consolidated volume 09/15/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
GROZ | LRND | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
GROZ | LRND | |
|---|---|---|
| Last price | $32.51 | $45.78 |
| 1D performance | -0.61% | -0.50% |
| AuM | $115.45 M | $437.25 M |
| E/R | 1.14% | 0.15% |
GROZ | LRND | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | Zacks ETFs | New York Life Investments |
| Benchmark | - | NYLI U.S. Large Cap R&D Leaders Index |
| N° of holdings | 41 | 520 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 5, 2024 | February 8, 2022 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
